Efficacy and safety of immunotherapy for head and neck squamous cell carcinoma: a meta-analysis of randomized clinical trials by Cailing Jiang, Shuqin Wang, Lijun Zhu

“…Furthermore, the occurrence of grade 3 or higher adverse events related to the drugs was lower than systematic therapy (OR 0.35, 95% CI 0.17-0.73).ConclusionsThe study has provided compelling evidence that immunotherapy is a significant benefit in OS for HNSCC patients, either R/M HNSCC or LA HNSCC, immunochemotherapy may benefit more for these patients, but double-agent immunotherapy showed no more benefit for R/M HNSCC patients.Systematic Review Registrationhttps://www.crd.york.ac.uk/, identifier CRD42023471570.…”
Get full text

Current Insights into Various In Vitro Dihaploidization Techniques Used in <i>Brassica</i> Oil Crops by Pavla Bryxová, Eloy Fernández-Cusimamani, Miroslav Klíma

“…Colchicine and trifluralin have proven to be efficient chromosome-doubling agents as well as important supplements that can increase the rate of embryogenesis. …”
Get full text